| scholarly article | Q13442814 |
| P2093 | author name string | Béla Nagy | |
| Ildikó Beke Debreceni | |||
| János Kappelmayer | |||
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin | Q24599137 | ||
| Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help) | Q24675460 | ||
| Platelet-based coagulation: different populations, different functions | Q26820857 | ||
| Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study | Q28195379 | ||
| Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack | Q28212443 | ||
| Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy | Q28220845 | ||
| A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V | Q28294206 | ||
| Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 | ||
| Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. | Q33187134 | ||
| Hyperresponsiveness of platelets in ischemic stroke | Q33286704 | ||
| Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation. | Q33328823 | ||
| Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications. | Q33329088 | ||
| The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis | Q33348594 | ||
| Programmed anuclear cell death delimits platelet life span. | Q33374664 | ||
| Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure | Q33399513 | ||
| A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry | Q33498117 | ||
| Whole blood analysis of reticulated platelets: improvements of detection and assay stability. | Q33504395 | ||
| The adhesion molecule P-selectin and cardiovascular disease | Q35601863 | ||
| Increased neutrophil-platelet adhesion in patients with unstable angina | Q71571191 | ||
| Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets--definition and detection of ticlopidine/clopidogrel effects | Q73013573 | ||
| Platelet microparticles and calcium homeostasis in acute coronary ischemias | Q73075680 | ||
| P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease | Q73333604 | ||
| Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy | Q73617235 | ||
| Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts | Q74156372 | ||
| Circulating platelets show increased activation in patients with acute cerebral ischemia | Q74671046 | ||
| Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease | Q80387665 | ||
| Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus | Q80541092 | ||
| Reticulated platelets in acute coronary syndrome: a marker of platelet activity | Q80998653 | ||
| Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke | Q83206934 | ||
| Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions | Q83409531 | ||
| Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension | Q83960841 | ||
| Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study | Q84023565 | ||
| Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients | Q84820508 | ||
| Increased mean platelet volume in primary Raynaud's phenomenon | Q84977486 | ||
| Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment | Q85631129 | ||
| The emerging value of P-selectin as a disease marker | Q35808636 | ||
| Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy | Q37163821 | ||
| In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function | Q37273254 | ||
| Procoagulant platelets: are they necrotic? | Q37764243 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation | Q37971941 | ||
| Selectins. | Q40388550 | ||
| Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization | Q41302239 | ||
| Platelet-leukocyte mixed conjugates in patients with atrial fibrillation | Q42454071 | ||
| Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy. | Q42455401 | ||
| Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity | Q42461765 | ||
| Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). | Q42510258 | ||
| Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets | Q42932159 | ||
| Protein phosphatase inhibitor calyculin – A modulates activation markers in TRAP-stimulated human platelets | Q42952515 | ||
| Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication | Q43252660 | ||
| Platelet-leukocyte cross talk in whole blood | Q43511991 | ||
| The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy | Q43775586 | ||
| Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface | Q43863360 | ||
| Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets | Q44155386 | ||
| Flow cytometric measurement of microparticles: pitfalls and protocol modifications | Q44802584 | ||
| Coated-platelet levels may explain some variability in clinical phenotypes observed with severe hemophilia | Q45857184 | ||
| Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program | Q46098869 | ||
| Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke | Q46114202 | ||
| Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days | Q46292966 | ||
| Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone | Q46670831 | ||
| The role of platelets CD40 ligand (CD154) in acute coronary syndromes | Q46761881 | ||
| Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke | Q46817734 | ||
| Coated platelet levels correlate with bleed volume in patients with spontaneous intracerebral hemorrhage | Q46982519 | ||
| Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. | Q47387608 | ||
| Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke | Q47623201 | ||
| Course of platelet activation markers after ischemic stroke | Q48456057 | ||
| Coated-platelet levels are elevated in patients with transient ischemic attack | Q48839618 | ||
| Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction | Q49031698 | ||
| Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke | Q49036941 | ||
| Platelet activation and reactivity in the convalescent phase of ischaemic stroke. | Q50275282 | ||
| Platelet activation and blood coagulation. | Q50281720 | ||
| Binding of plasma factor XIII to thrombin-receptor activated human platelets. | Q50329070 | ||
| Reticulated platelets. | Q50478561 | ||
| Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1). | Q51039155 | ||
| Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. | Q51587051 | ||
| Thrombin-triggered platelet apoptosis. | Q53600485 | ||
| Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction | Q56945105 | ||
| Tissue Factor in Patients With Acute Coronary Syndromes | Q57398785 | ||
| Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina | Q58314222 | ||
| Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets | Q58487090 | ||
| Inherited platelet disorders | Q59384161 | ||
| P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction | Q62977663 | ||
| Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation | Q68940569 | ||
| Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease | Q70731148 | ||
| P433 | issue | 4 | |
| P921 | main subject | flow cytometry | Q1141429 |
| P304 | page(s) | 124-134 | |
| P577 | publication date | 2013-01-16 | |
| P1433 | published in | EJIFCC | Q27714915 |
| P1476 | title | Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers | |
| P478 | volume | 23 |
| Q33705173 | Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients |
| Q42363103 | Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk |
| Q55649547 | Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia. |
Search more.